New York, NY (PRWEB) March 12, 2014
Hundreds of GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) filed in the wake of the 2012 GranuFlo and NaturaLyte dialysis concentrate recall continue to move forward in U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP reports. According to an Order dated March 5, 2014, the Court has established procedures for identifying the dialysis concentrates administered to plaintiffs just before they sustained their alleged heart injuries. The Order only applies to plaintiffs who received their last treatment at a clinic owned by Fresenius Medical Care, the manufacturer of GranuFlo and NaturaLyte. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428)
“Our Firm is representing numerous clients in this litigation who were allegedly harmed by products included in the GranuFlo recall. This order will allow plaintiffs treated at Fresenius clinics to obtain information important to their claims,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free legal reviews to dialysis patients who were allegedly harmed by GranuFlo or NaturaLyte.
GranuFlo Recall Litigation
Court documents indicate that more than 500 product liability claims have been filed in the District of Massachusetts on behalf of individuals who allegedly suffered heart attacks, strokes, and other potentially deadly heart events following the administration of GranuFlo or NaturaLyte. The two dialysis concentrates were the subject of a Class I recall in 2012 after they were linked to metabolic alkalosis, and dangerous elevation of bicarbonate in the blood that can cause dialysis patients to suffer sudden and catastrophic cardiovascular events.
GranuFlo lawsuit plaintiffs accuse Fresenius Medical Care of failing to provide adequate warnings regarding the potential for GranuFlo and NaturaLyte to cause deadly heart side effects. According to court documents, these claims note that Fresenius issued a memo to its own dialysis clinics in November 2011 that detailed the heart risks associated with GranuFlo and NaturaLyte. The lawsuits raise questions as to why Fresenius did nothing at that time to warn other dialysis clinics outside of its network about these dangers.
Additional GranuFlo lawsuits which put forth similar allegations have been consolidated at the state level in Massachusetts’ Middlesex County Superior Court. (In re Consolidated Fresenius Cases, No. MICV2013-03400-O).
Dialysis patients who allegedly suffered serious heart injuries associated with the GranuFlo recall may be entitled to compensation from Fresenius Medical Care. To learn more about filing a GranuFlo lawsuit, please visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/granuflolawsuit. For more information, and to arrange for a free case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP